首页> 外文期刊>Molecular human reproduction. >The search for biomarkers of human embryo developmental potential in IVF: A comprehensive proteomic approach
【24h】

The search for biomarkers of human embryo developmental potential in IVF: A comprehensive proteomic approach

机译:在体外受精中寻找人类胚胎发育潜能的生物标记:全面的蛋白质组学方法

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of these studies was to identify differentially expressed peptides/proteins in the culture media of embryos grown during in vitro fertilization (IVF) treatment to establish their value as biomarkers predictive of implantation potential and live birth. Micro-droplets of embryo culture media from IVF patients (conditioned) and control media maintained under identical culture conditions were collected and frozen at 80°C on Days 23 of in vitro development prior to analysis. The embryos were transferred on Day 3. The peptides were affinity purified based on their physico-chemical properties and profiled by mass spectrometry for differential expression. The identified proteins were further characterized by western blot and ELISA, and absolute quantification was achieved by multiple reaction monitoring (MRM). We identified up to 14 differentially regulated peptides after capture using paramagnetic beads with different affinities. These differentially expressed peptides were used to generate genetic algorithms (GAs) with a recognition capability of 7184 for embryo transfer cycles resulting in pregnancy and 7589 for those with failed implantation. Several peptides were further identified as fragments of Apolipoprotein A-1, which showed consistent and significantly reduced expression in the embryo media samples from embryo transfer cycles resulting in viable pregnancies. Western blot and ELISA, as well as quantitative MRM results, were confirmatory. These results demonstrated that peptide/protein profiles from the culture medium during early human in vitro development can discriminate embryos with highest and lowest implantation competence following uterine transfer. Further prospective studies are needed to establish validated thresholds for clinical application.
机译:这些研究的目的是鉴定在体外受精(IVF)处理过程中生长的胚胎培养基中差异表达的肽/蛋白质,以确立其作为预测植入潜力和活产的生物标志物的价值。收集来自IVF患者(条件)和维持在相同培养条件下的对照培养基的微滴胚胎培养基,并在分析前体外培养的第23天在80℃下冷冻。在第3天转移胚胎。根据肽的理化性质对其进行亲和纯化,并通过质谱分析其差异表达。通过蛋白质印迹和ELISA进一步鉴定鉴定出的蛋白质,并通过多反应监测(MRM)实现绝对定量。在使用具有不同亲和力的顺磁珠捕获后,我们鉴定了多达14种差异调节的肽。这些差异表达的肽用于生成遗传算法(GA),对于导致怀孕的胚胎移植周期,识别能力为7184;对于植入失败的人,识别能力为7589。进一步鉴定了几种肽作为载脂蛋白A-1的片段,它们在胚胎移植周期的胚胎培养基样品中显示出一致且显着减少的表达,从而导致可行的怀孕。 Western印迹和ELISA以及定量MRM结果均得到证实。这些结果表明,在人类早期体外发育过程中,来自培养基的肽/蛋白质谱可以区分子宫转移后具有最高和最低植入能力的胚胎。需要进行进一步的前瞻性研究,以建立临床应用的有效阈值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号